TransMedics Group, Inc. (TMDX:NASDAQ) closed at $91.38 on November 13, 2026, down 0.67% on the day. The stock trades 41.4% below its 52-week high of $156.00 and 52.0% above its 52-week low of $60.11. Over the past year, it lost 20.5%. TransMedics Group, Inc. is part of the Health Care sector (Biotechnology: Electromedical & Electrotherapeutic Apparatus).
In 252 trading sessions since November 13, 2025, TMDX closed higher on 119 days (47%). Its best day was November 6, 2026 (+27.92%) and its worst was May 6, 2026 (-23.19%). The stock moved 10% or more in a single session 4 times. It opened at least 5% above the previous day's high 1 time.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the OCS to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes the technology to replicate near-physiologic conditions for donor organs outside of the human body.
Find more stocks like TMDX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.